Therapeutic potential of valproic acid for retinitis pigmentosa

The British Journal of Ophthalmology
C M ClemsonS Kaushal

Abstract

To examine the efficacy and safety of valproic acid (VPA) in patients with retinitis pigmentosa (RP). Thirteen eyes were examined before and after brief treatment (average 4 months) with VPA. Visual fields (VF) for each eye were defined using digitised Goldmann Kinetic Perimetry tracings. VF areas were log-transformed and VF loss/gain relative to baseline was calculated. Visual acuity was measured using a Snellen chart at a distance of 20&emsp14;feet (6.1 m). Values were converted to the logarithm of the minimum angle of resolution (logMAR) score. Nine eyes had improved VF with treatment, two eyes had decreased VF and two eyes experienced no change, with an overall average increase of 11%. Assuming typical loss in VF area without treatment, this increase in VF was statistically significant (p<0.02). An average decrease (0.172) in the logMAR scores was seen in these 13 eyes, which translates to a positive change in Snellen score of approximately 20/47 to 20/32, which was significant (p<0.02) assuming no loss in acuity without treatment. Side effects were mild and well tolerated. Treatment with VPA is suggestive of a therapeutic benefit to patients with RP. A placebo-controlled clinical trial will be necessary to assess the effic...Continue Reading

Citations

Feb 22, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C M Poloschek, H Jägle
May 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ekaterina S LobanovaVadim Y Arshavsky
Aug 10, 2011·Cold Spring Harbor Perspectives in Biology·Radouil TzekovShalesh Kaushal
Apr 23, 2013·The British Journal of Ophthalmology·Sheena BhallaChristine N Kay
Jun 24, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Atul KumarAnnu Chohan
Feb 11, 2014·International Ophthalmology·Tapas Ranjan PadhiTaraprasad Das
Sep 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Rajesh C RaoShiming Chen
Dec 1, 2012·Ophthalmology and Therapy·P Mahesh ShanmugamManish Saxena
May 21, 2013·FEBS Letters·Dimitra AthanasiouMichael E Cheetham
Jun 27, 2015·Progress in Retinal and Eye Research·Viviana GuadagniEnrica Strettoi
Nov 14, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yuanyuan ChenKrzysztof Palczewski
Mar 18, 2016·PloS One·Glenn P LoboStephanie A Hagstrom
Feb 10, 2019·International Journal of Molecular Sciences·Mor DahbashTami Livnat
Apr 9, 2016·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Michael P BarryGislin Dagnelie
Mar 9, 2017·Oxidative Medicine and Cellular Longevity·Atsuko KimuraTakayuki Harada
Jul 24, 2018·Translational Vision Science & Technology·Jacque L DuncanUNKNOWN and the Foundation Fighting Blindness Scientific Advisory Board
Dec 27, 2018·International Ophthalmology Clinics·Angeline L WangMitul C Mehta
Jun 19, 2018·Molecular Neurobiology·Ishaq A ViringipurampeerKevin Gregory-Evans
Sep 13, 2017·Scientific Reports·María Guadalupe Herrera-HernándezPere Garriga
Nov 22, 2020·Environmental Toxicology·Shaista ChaudharySuhel Parvez
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Neda RazzaghiPere Garriga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.